Shares Of Galena Biopharma Plunged On Thursday, Company Announces Public Offering
Galena Biopharma, a biopharmaceutical company that focuses on oncology therapeutics, stated on Wednesday afternoon it will offer shares of its common stock and warrants in an underwritten public offering.
Galena Biopharma stated it will use the net proceeds to fund its ongoing Phase 3 PRESENT study and other clinical trials, in addition to augmenting its working capital for general corporate purposes.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.